AK101

· Akeso Biopharma

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for AK101, covering 2023-03-02 to 2025-03-03. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of AK101 in Subjects With Moderate to Severe Plaque Psoriasis [Phase 1, Phase 2]